These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 23835434)
21. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964 [TBL] [Abstract][Full Text] [Related]
22. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Fang DD; Kim YJ; Lee CN; Aggarwal S; McKinnon K; Mesmer D; Norton J; Birse CE; He T; Ruben SM; Moore PA Br J Cancer; 2010 Apr; 102(8):1265-75. PubMed ID: 20332776 [TBL] [Abstract][Full Text] [Related]
23. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells. Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129 [TBL] [Abstract][Full Text] [Related]
24. Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell-like cells. Kang MJ; Kim HP; Lee KS; Yoo YD; Kwon YT; Kim KM; Kim TY; Yi EC Proteomics; 2013 May; 13(10-11):1714-25. PubMed ID: 23554123 [TBL] [Abstract][Full Text] [Related]
25. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors. Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654 [TBL] [Abstract][Full Text] [Related]
26. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors. Hong IS; Lee HY; Nam JS Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037 [TBL] [Abstract][Full Text] [Related]
28. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039 [TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243 [TBL] [Abstract][Full Text] [Related]
30. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. Prabhu VV; Allen JE; Dicker DT; El-Deiry WS Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124 [TBL] [Abstract][Full Text] [Related]
31. Dynamic regulation of cancer stem cells and clinical challenges. Ni C; Huang J Clin Transl Oncol; 2013 Apr; 15(4):253-8. PubMed ID: 22926945 [TBL] [Abstract][Full Text] [Related]
32. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022 [TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell (CSC) resistance drivers. Najafi M; Mortezaee K; Majidpoor J Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455 [TBL] [Abstract][Full Text] [Related]
34. EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Feng Y; Dai X; Li X; Wang H; Liu J; Zhang J; Du Y; Xia L Cell Prolif; 2012 Oct; 45(5):413-9. PubMed ID: 22925500 [TBL] [Abstract][Full Text] [Related]
35. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer. Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309 [TBL] [Abstract][Full Text] [Related]
36. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells. Zhang Z; Deng Q; Xiao C; Li Z; Yang X Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133 [TBL] [Abstract][Full Text] [Related]
37. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment. Onzi GR; Ledur PF; Hainzenreder LD; Bertoni AP; Silva AO; Lenz G; Wink MR Cytotherapy; 2016 Jul; 18(7):828-37. PubMed ID: 27210718 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
40. Colon cancer: cancer stem cells markers, drug resistance and treatment. Kozovska Z; Gabrisova V; Kucerova L Biomed Pharmacother; 2014 Oct; 68(8):911-6. PubMed ID: 25458789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]